InvestorsHub Logo
Followers 0
Posts 83
Boards Moderated 0
Alias Born 11/25/2016

Re: Amigo Mike post# 24285

Friday, 02/24/2017 11:03:02 AM

Friday, February 24, 2017 11:03:02 AM

Post# of 38634
The 2.7B is for all dosages regular and extended release. Their pipeline numbers are for all generic sales of metformin.

Its hard to calculate earnings since a good partner can displace the several Indian manufacturers if they have a good relationship with their suppliers and an equivalent price target.

Worst case (SWAG)..assuming they manufacture the drug...

600m/28=22m x0.125=2.75M=680k per QTR but again the upside is huge since distributors have there preferred suppliers....